期刊文献+

系统性红斑狼疮患者外周血单个核细胞c-kit受体表达的研究 被引量:2

Expression of cell kit on peripheral blood monocytes of patients with systemic lupus erythematosus
原文传递
导出
摘要 目的 探讨系统性红斑狼疮 (SLE)患者外周血单个核细胞 (PBMC)中c kit受体的表达及其临床意义。方法 采用免疫荧光标记、流式细胞仪检侧SLE患者PBMC的c kit受体蛋白(CD117)表达 ,反转录 聚合酶链式反应 (RT PCR)检测其c kitmRNA的表达水平 ,并分别与正常人比较。结果 SLE患者PBMC中c kit受体及其mRNA表达水平与正常组相比显著增高 (P <0 0 5 ) ;活动期与非活动期相比显著增高 (P <0 0 5 ) ;非活动期SLE患者PBMC的c kit受体蛋白表达与正常人差异无显著性 (P >0 0 5 )。PBMC的c kit受体蛋白表达与其SLEDAI显著相关 (P <0 0 1)。结论 SLE患者PBMCc kit受体蛋白水平及其mRNA表达水平均显著高于正常人 ,且与疾病活动呈正相关 ,c kit受体可能在SLE的病程变化中起着重要作用。 Objective To determine the level of cell KIT (c kit) of peripheral blood monocytes (PBMCs) in patients with recent onset systemic lupus erythematosus (SLE),and analyze the relationship between the c kit of PBMCs and clinical parameters.Methods The level of c kit of PBMCs in patients with SLE was estimated with flow cytometry,and c kit mRNA was examined by reverse transcript polymerase chain reaction (RT PCR).Results The c kit level of PBMCs in SLE patients ( n =47) was significantly higher than that in healthy controls ( n =20),the c kit level of PBMCs in active patients ( n =27) was significantly higher than that in inactive patients ( n =20).There was no significant difference between active and inactive patients ( P >0 05).Conclusion C kit level may be more closely related to the clinical parameters in SLE patients,which may reflect the clinical status of SLE patients.
出处 《中华风湿病学杂志》 CAS CSCD 2003年第4期198-200,共3页 Chinese Journal of Rheumatology
基金 江苏省自然科学基金资助项目 (BQ2 0 0 0 2 0 )
关键词 系统性红斑狼疮 外周血 单个核细胞 C-KIT 受体 表达 Lupus erythematosus,systemic Monocytes Proto oncogene protein c kit
  • 相关文献

参考文献11

  • 1孙凌云,欧阳健,张杏书.造血干细胞移植治疗自身免疫病[J].中华风湿病学杂志,1998,2(2):111-113. 被引量:8
  • 2Zsebo KM;Williams DA;Geissler EN.Stem cell factor is encoded at the S1 locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor[J],1990.
  • 3Ferrari S;Grande A;Manfredini R.Expression of interleukins 1,3,6,stem cell factor and their receptors in acute leukemia blast cells and in normal peripheral lymphocytes and monocytes,1993.
  • 4Tan EM;Cohen AS Fries JF;et al;The.1982 revised criteria for the classification of systemic lupus erythematosus,1982.
  • 5陈顺乐;许以华;施守义.系统性红斑狼疮诊断标准的研究,1987.
  • 6Bombardier C;Gladman D D;Urowitz M B.Derivation of the SLEDAI:a disease activity index for lupus patients.The Committee on Prognosis Studies in SLE,1992.
  • 7Michael C;Heinrich DC;Dooley AC.Constitutive expression of stem factor gene by human stromal cells,1993.
  • 8Smithey BE;Pappo AS;Hill DA.C-kit expression in pediatric solid tumors:a comparative immunohistochemical study[J],2002(4).
  • 9邵宗鸿,陈桂彬,张泓,贾海蓉,郑以州,张益枝,储榆林,李莉.再生障碍性贫血患者骨髓造血干/祖细胞c-kit受体表达[J].中华血液学杂志,1999,20(10):532-534. 被引量:8
  • 10Kitoh T;Ishikawa H;Sawada S.Significance of stem cell factor and soluble KIT in patients with systemic lupus erythematosus,1998.

二级参考文献3

  • 1Shao Z H,Am J Hematol,1998年,59期,185页
  • 2张之南,血液病诊断及疗效标准(第2版),1998年,33页
  • 3McGuckin C P,Eur J Haematol,1996年,57卷,72页

共引文献14

同被引文献18

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部